Challenge-mig: a phase 4, randomized, double-blind, double-dummy study comparing the efficacy and safety of galcanezumab versus rimegepant for prevention of episodic migraine

• Published in: Journal of the neurological sciences Vol. 455; p. 121116
• Main Authors: Schwedt, Todd J., Myers Oakes, Tina M., Martinez, James M., Vargas, Bert B., Pandey, Hitendra N., Pearlman, Eric M., Richardson, Diane R., Varnado, Oralee J., Meyer, Michael Cobas, Goadsby, Peter J.
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.12.2023
• Subjects: Neurology